Page last updated: 2024-10-25

amphetamine and Depressive Disorder, Major

amphetamine has been researched along with Depressive Disorder, Major in 11 studies

Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research Excerpts

ExcerptRelevanceReference
"To systematically review the literature on the therapeutic use of amphetamine, lisdexamfetamine and methylphenidate in elderly population with and without dementia."5.05Amphetamine Use in the Elderly: A Systematic Review of the Literature. ( Colpo, GD; John, V; Rocha, NP; Sassi, KLM; Teixeira, AL, 2020)
"The use of traditional psychostimulants (methylphenidate and dexamphetamine) and stimulant-like drugs (modafinil and armodafinil) for the treatment of depression is a growing concern given the lack of research evidence supporting their effectiveness."4.93Stimulants for depression: On the up and up? ( Bassett, D; Boyce, P; Byrow, Y; Hopwood, M; Lyndon, W; Malhi, GS; Mulder, R; Murray, G; Porter, R; Singh, A, 2016)
" However, the relationship between ATS use and mental disorders is complex, with divergent patterns of association for ecstasy and methamphetamine use."4.02The prevalence of mental health disorders among young adults who use amphetamine-type stimulants, compared to young adults who do not. ( Najman, JM; Pourmarzi, D; Smirnov, A; Thoradeniya, MR; Wessel, EL, 2021)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19902 (18.18)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's3 (27.27)24.3611
2020's3 (27.27)2.80

Authors

AuthorsStudies
Sassi, KLM1
Rocha, NP1
Colpo, GD1
John, V1
Teixeira, AL1
Kangas, BD1
Wooldridge, LM1
Luc, OT1
Bergman, J1
Pizzagalli, DA1
Thoradeniya, MR1
Wessel, EL1
Pourmarzi, D1
Najman, JM1
Smirnov, A1
Hales, CA1
Houghton, CJ1
Robinson, ESJ1
Homan, P1
Drevets, WC2
Hasler, G2
Malhi, GS1
Byrow, Y1
Bassett, D1
Boyce, P1
Hopwood, M1
Lyndon, W1
Mulder, R1
Porter, R1
Singh, A1
Murray, G1
Luckenbaugh, DA1
Snow, J1
Meyers, N1
Waldeck, T1
Geraci, M1
Roiser, J1
Knutson, B1
Charney, DS1
CLANCY, J1
Janowsky, DS1
Parsey, RV1
Oquendo, MA1
Zea-Ponce, Y1
Rodenhiser, J1
Kegeles, LS1
Pratap, M1
Cooper, TB1
Van Heertum, R1
Mann, JJ1
Laruelle, M1
Mashkovskii, MD1
Polezhaeva, AI1
Avrutskii, GIa1
Vertozgadova, OP1
Smulevich, AB1

Reviews

3 reviews available for amphetamine and Depressive Disorder, Major

ArticleYear
Amphetamine Use in the Elderly: A Systematic Review of the Literature.
    Current neuropharmacology, 2020, Volume: 18, Issue:2

    Topics: Aged; Amphetamine; Dementia; Depressive Disorder, Major; Humans; Lisdexamfetamine Dimesylate; Methyl

2020
Stimulants for depression: On the up and up?
    The Australian and New Zealand journal of psychiatry, 2016, Volume: 50, Issue:3

    Topics: Amphetamine; Antidepressive Agents; Benzhydryl Compounds; Bipolar Disorder; Central Nervous System S

2016
Depression and dysphoria effects on the interpersonal perception of negative and positive moods and caring relationships: effects of antidepressants, amphetamine, and methylphenidate.
    Current psychiatry reports, 2003, Volume: 5, Issue:6

    Topics: Amphetamine; Antidepressive Agents; Anxiety Disorders; Central Nervous System Stimulants; Clinical T

2003

Trials

2 trials available for amphetamine and Depressive Disorder, Major

ArticleYear
The effects of catecholamine depletion on the neural response to fearful faces in remitted depression.
    The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:9

    Topics: Adolescent; Adult; alpha-Methyltyrosine; Amphetamine; Catecholamines; Central Nervous System Stimula

2014
Reward processing after catecholamine depletion in unmedicated, remitted subjects with major depressive disorder.
    Biological psychiatry, 2009, Aug-01, Volume: 66, Issue:3

    Topics: Adolescent; Adult; Amphetamine; Catecholamines; Central Nervous System Stimulants; Cross-Over Studie

2009

Other Studies

6 other studies available for amphetamine and Depressive Disorder, Major

ArticleYear
Empirical validation of a touchscreen probabilistic reward task in rats.
    Translational psychiatry, 2020, 08-13, Volume: 10, Issue:1

    Topics: Amphetamine; Anhedonia; Animals; Depressive Disorder, Major; Female; Learning; Rats; Reward

2020
The prevalence of mental health disorders among young adults who use amphetamine-type stimulants, compared to young adults who do not.
    Drug and alcohol review, 2021, Volume: 40, Issue:4

    Topics: Amphetamine; Anxiety Disorders; Australia; Depressive Disorder, Major; Humans; Mania; Mental Disorde

2021
Behavioural and computational methods reveal differential effects for how delayed and rapid onset antidepressants effect decision making in rats.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2017, Volume: 27, Issue:12

    Topics: Acoustic Stimulation; Amphetamine; Analgesics; Animals; Antidepressive Agents; Association Learning;

2017
OTHER ASPECTS OF DEPRESSION.
    Geriatrics, 1965, Volume: 20

    Topics: Alcoholism; Amphetamine; Antidepressive Agents; Barbiturates; Bipolar Disorder; Brain Diseases; Depr

1965
Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression.
    Biological psychiatry, 2001, Sep-01, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Amphetamine; Benzamides; Corpus Striatum; Depressive Disorder, Major; Dopamine; F

2001
[The pharmacologic properties and therapeutic effectiveness of the new antidepressant preparation Azaphen].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1969, Volume: 69, Issue:8

    Topics: Adult; Aged; Amphetamine; Animals; Antidepressive Agents; Bipolar Disorder; Cats; Depression; Depres

1969